FC
RGNX icon

FORA Capital’s Regenxbio RGNX Stock Holding History

FORA Capital’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,539
Closed -$137K – 763
2021
Q2 		$137K Buy
3,539
+2,075
+142% +$74.2K 0.03% 520
2021
Q1 		$50K Sell
1,464
-1,680
-53% -$71.7K 0.02% 546
2020
Q4 		$143K Buy
+3,144
New +$110K 0.02% 582
2020
Q1 		– Sell
-4,113
Closed -$169K – 1285
2019
Q4 		$169K Buy
+4,113
New +$162K 0.02% 655

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

FORA Capital's RGNX Position: Q3 2021 in Review

FORA Capital sold out of Regenxbio (RGNX) in Q3 2021, closing a stake of 3,539 shares — an estimated $137K sold.

FORA Capital first reported a position in RGNX in Q4 2019 and held it in 4 quarters. The position peaked at $169K in Q4 2019. 182 funds tracked by Wall St. Rank hold RGNX as of Q3 2021.

  • FORA Capital reported no remaining Regenxbio position as of Q3 2021 after selling out during the quarter.
  • FORA Capital sold 3,539 Regenxbio shares in Q3 2021, an estimated $137K.
  • FORA Capital first reported a position in Regenxbio in Q4 2019 and held it in 4 quarters.
  • FORA Capital's Regenxbio position peaked at $169K in Q4 2019.
  • 182 funds tracked by Wall St. Rank held Regenxbio as of Q3 2021.

Based on FORA Capital's 13F filing for Q3 2021, filed 15 Nov 2021.